NCT06689553 - Percutaneously Delivered Automated Continual Fluid Removal System in Patients With Advanced Diuretic-Resistant Heart Failure | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 28, 2025

Primary Completion Date

July 30, 2026

Study Completion Date

December 30, 2026

Conditions

Heart Failure

Interventions

DEVICE

Automated Continual Fluid Removal System

The intraperitoneal device is percutaneously implanted via mini laparotomy, under local anaesthesia and sedation, and connected to the wearable rechargeable pump through extracorporeal tubing. The device aims to remove excess fluids in heart failure patients with diuretic resistance

Trial Locations (3)

11000

RECRUITING

University Clinical Centre of Serbia, Belgrade

11080

RECRUITING

"University Clinical Hospital Medical Center Bezanijska kosa", Belgrade

17 46010

NOT_YET_RECRUITING

Hospital Clínico Universitario de Valencia-España, Valencia